Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Neoplasm Transplantation. Found 20 abstracts

Burns KE, Robinson MK, Thevenin D. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates. Molecular pharmaceutics. 2015 Apr 06;12(4):1250-8.   PMCID: PMC4476257
Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams S. CTLA-4 blockade synergizes therapeutically with PARP-inhibition in BRCA1-deficient ovarian cancer. Cancer Immunol Res. 2015 Jul 02;3(11):1257-68.   PMCID: 4984269
Kalra N, Zhang J, Thomas A, Xi L, Cheung M, Talarchek J, Burkett S, Tsokos MG, Chen Y, Raffeld M, Miettinen M, Pastan I, Testa JR, Hassan R. Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma. BMC Cancer. 2015 Jan;15:376.   PMCID: PMC4431029
Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, Tulin A, Uzzo RG, Kolenko VM. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. Br J Cancer. 2014 Feb 18;110(4):899-907.   PMCID: PMC3929888
Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, Delmas V, Larue L. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene. 2013 Apr 25;32(17):2230-8.   PMCID: Pmc3637425
Cordero AB, Kwon Y, Hua X, Godwin AK. In vivo imaging and therapeutic treatments in an orthotopic mouse model of ovarian cancer. Journal of visualized experiments : JoVE. 2010 Jan;(42).   PMCID: PMC2935696
Patel RR, Sengupta S, Kim HR, Klein-Szanto AJ, Pyle JR, Zhu F, Li T, Ross EA, Oseni S, Fargnoli J, Jordan VC. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors. Eur J Cancer. 2010 Jun;46(9):1537-53.   PMCID: PMC2927957
Pimkina J, Murphy ME. ARF, autophagy and tumor suppression. Autophagy. 2009 Apr;5(3):397-9.   PMCID: PMC2667648
Kim SH, Nakagawa H, Navaraj A, Naomoto Y, Klein-Szanto AJ, Rustgi AK, El-Deiry WS. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras. Cancer Res. 2006 Nov;66(21):10415-24.
Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Molecular Cancer Therapeutics. 2005 Mar;4(3):351-60.
Shalaby WS, Yeh H, Woo E, Hendren S, Corbett JT, Gray H, June CH, Shalaby SW. Development of novel substrates for tumor immunotherapy. J Control Release. 2003 Aug 28;91(1-2):209-24.
Mahloogi H, Bassi DE, Klein-Szanto AJ. Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4. Carcinogenesis. 2002 Apr;23(4):565-72.
Mercapide J, Lopez De Cicco R, Bassi DE, Castresana JS, Thomas G, Klein-Szanto AJ. Inhibition of Furin-mediated Processing Results in Suppression of Astrocytoma Cell Growth and Invasiveness. Clin Cancer Res. 2002 Jun;8(6):1740-6.
Bassi DE, Lopez De Cicco R, Mahloogi H, Zucker S, Thomas G, Klein-Szanto AJ. Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10326-31.
Gabrielson EW, Pinn ML, Testa JR, Kuhajda FP. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res. 2001 Jan;7(1):153-7.
Iyer RV, Haynes PT, Schneider RF, Movsas B, Chapman JD. Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and. J Nucl Med. 2001 Feb;42(2):337-44.
Bao R, Selvakumaran M, Hamilton TC. Use of a surrogate marker (human secreted alkaline phosphatase) to monitor in vivo tumor growth and anticancer drug efficacy in ovarian cancer xenografts. Gynecol Oncol. 2000 Sep;78(3 Pt 1):373-9.
St John LS, Sauter ER, Herlyn M, Litwin S, Adler-Storthz K. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53. Cancer Gene Ther. 2000 May;7(5):749-56.
Qian M, Chen SH, von Hofe E, Gallo JM. Pharmacokinetics and tissue distribution of a DNA-methyltransferase antisense (MT-AS) oligonucleotide and its catabolites in tumor-bearing nude mice. The Journal of pharmacology and experimental therapeutics. 1997 Aug;282(2):663-70.
Wu Y, Barnabas N, Russo IH, Yang X, Russo J. Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. Carcinogenesis. 1997 May;18(5):1069-74.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Neoplasm Transplantation

Neoplasm Transplantation Mice metabolism Animal Cultured Tumor Cells Female genetics US Gov't Support-PHS pathology Human Non-US Gov't Support drug therapy SCID Mice antagonists & inhibitors pharmacology Transfection Tumor Cell Line Nude Mice therapy methods Heterologous Transplantation US Gov't Support-Non-PHS Antineoplastic Agents Cell Proliferation Neoplastic Cell Transformation Time Factors biosynthesis Ovarian Neoplasms Cell Line Flow Cytometry Lung Neoplasms Breast Neoplasms Western Blotting Neoplasms enzymology Male physiology Rats drug effects cytology Neoplasm Invasiveness Serine Endopeptidases Mesothelioma Complementary DNA Apoptosis Prostatic Neoplasms Keratinocytes Membrane Proteins analysis Immunotherapy Biological Tumor Markers Autophagy Metalloendopeptidases Cell Division Transformed Cell Line analogs & derivatives Subtilisins therapeutic use In Vitro Immunohistochemistry Experimental Neoplasms Squamous Cell Carcinoma Hydrogen-Ion Concentration chemistry Inbred BALB C Mice Chloroquine Xenograft Model Antitumor Assays Drug Dose-Response Relationship p53 Genes Alanine administration & dosage Tumor Suppressor Proteins immunology Proto-Oncogene Proteins c-akt Immunoenzyme Techniques alpha 1-Antitrypsin Chromosome Mapping Mutation Angiogenesis Inhibitors Fatty Acid Synthetase Complex Melanoma Antifungal Antibiotics Protein p53 Vascular Endothelial Growth Factor A Astrocytoma Extracellular Matrix Reactive Oxygen Species Gene Expression Profiling Middle Aged blood ADP-Ribosylation Factor 1 Drug Delivery Systems Fibroblasts Electron Microscopy Area Under Curve CD28 Antigens diagnostic use Molecular Models Non-US Gov't Research Support IGF Type 1 Receptor DNA Repair Catalytic Domain Binding Sites CTLA-4 Antigen targeted drug delivery Luciferases Cyclins Microelectrodes Carcinogens Kinetics Phosphatidylcholines Half-Life Ubiquitin-Protein Ligases T-Lymphocyte Subsets Animal Disease Models beta Catenin deficiency Oncogenes Young Adult Diagnostic Imaging bcl-X Protein DNA Modification Methylases Biological Models Pyrroles Paclitaxel Reverse Transcriptase Polymerase Chain Reaction Pharmaceutical Chemistry etiology Circular Dichroism Gene Silencing Oligopeptides Complementary) 0 (DNA Anesthesia Preclinical Drug Evaluation Cultured Cells Cell Hypoxia myc Genes Phosphorylation Oximes Epidermal Growth Factor Receptor Brain Neoplasms Microsatellite Repeats TOR Serine-Threonine Kinases Cerulenin Alkaline Phosphatase Triple Negative Breast Neoplasms HEK293 Cells Capillary Electrophoresis Cell Survival Multiprotein Complexes
Last updated on Friday, August 14, 2020